Jinhai Medical Technology Limited (HKG:2225)

Jinhai Medical Technology Statistics

Total Valuation

HKG:2225 has a market cap or net worth of HKD 10.58 billion. The enterprise value is 10.63 billion.

Market Cap	10.58B
Enterprise Value	10.63B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2225 has 5.29 billion shares outstanding. The number of shares has increased by 1.44% in one year.

Current Share Class	5.29B
Shares Outstanding	5.29B
Shares Change (YoY)	+1.44%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	47.83%
Owned by Institutions (%)	0.03%
Float	2.76B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	44.19
PB Ratio	61.79
P/TBV Ratio	63.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-77.76
EV / Sales	44.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-126.88

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.53.

Current Ratio	1.17
Quick Ratio	1.04
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	-1.08
Interest Coverage	-31.22

Financial Efficiency

Return on equity (ROE) is -70.57% and return on invested capital (ROIC) is -68.20%.

Return on Equity (ROE)	-70.57%
Return on Assets (ROA)	-26.30%
Return on Invested Capital (ROIC)	-68.20%
Return on Capital Employed (ROCE)	-80.91%
Weighted Average Cost of Capital (WACC)	4.61%
Revenue Per Employee	522,702
Profits Per Employee	-298,481
Employee Count	458
Asset Turnover	0.68
Inventory Turnover	12.25

Taxes

In the past 12 months, HKG:2225 has paid 579,491 in taxes.

Income Tax	579,491
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +40.00% in the last 52 weeks. The beta is 0.07, so HKG:2225's price volatility has been lower than the market average.

Beta (5Y)	0.07
52-Week Price Change	+40.00%
50-Day Moving Average	1.50
200-Day Moving Average	1.30
Relative Strength Index (RSI)	64.12
Average Volume (20 Days)	12,716,037

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2225 had revenue of HKD 239.40 million and -136.70 million in losses. Loss per share was -0.03.

Revenue	239.40M
Gross Profit	37.83M
Operating Income	-149.16M
Pretax Income	-141.84M
Net Income	-136.70M
EBITDA	-122.72M
EBIT	-149.16M
Loss Per Share	-0.03

Balance Sheet

The company has 42.97 million in cash and 90.44 million in debt, with a net cash position of -47.47 million or -0.01 per share.

Cash & Cash Equivalents	42.97M
Total Debt	90.44M
Net Cash	-47.47M
Net Cash Per Share	-0.01
Equity (Book Value)	171.23M
Book Value Per Share	0.03
Working Capital	21.58M

Cash Flow

In the last 12 months, operating cash flow was -78.96 million and capital expenditures -4.82 million, giving a free cash flow of -83.78 million.

Operating Cash Flow	-78.96M
Capital Expenditures	-4.82M
Free Cash Flow	-83.78M
FCF Per Share	-0.02

Margins

Gross margin is 15.80%, with operating and profit margins of -62.31% and -57.10%.

Gross Margin	15.80%
Operating Margin	-62.31%
Pretax Margin	-59.25%
Profit Margin	-57.10%
EBITDA Margin	-51.26%
EBIT Margin	-62.31%
FCF Margin	n/a

Dividends & Yields

HKG:2225 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.44%
Shareholder Yield	-1.44%
Earnings Yield	-1.29%
FCF Yield	-0.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 12, 2024. It was a forward split with a ratio of 4.

Last Split Date	Dec 12, 2024
Split Type	Forward
Split Ratio	4

Scores

HKG:2225 has an Altman Z-Score of 32.7 and a Piotroski F-Score of 1.

Altman Z-Score	32.7
Piotroski F-Score	1